Anti-inflammatory Therapy for Coronary Atherosclerotic Heart Disease: Unanswered Questions Behind Existing Successes

Coronary atherosclerotic heart disease is a serious threat to human health. The results of the Canakinumab Anti-Inflammatory Thrombosis Outcome Study published in 2017 put an end to the perennial debate about the anti-inflammatory treatment of coronary atherosclerotic heart disease. In addition to i...

Full description

Bibliographic Details

Published in:	Frontiers in Cardiovascular Medicine
Main Authors:	Jun Ma, Xiaoping Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Subjects:	atherosclerotic heart disease interleukin 1β (IL-1β) interleukin 6 (IL-6) colchicine anti-inflammatory therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2020.631398/full